Premium
Arrowhead Pharmaceuticals Inc (ARWR)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-12 | Dr. Hongbo LuIndependent Director | -2,97k | 228,33k | Vente | 76,88 | 41,82k | -6,63% |
| 2026-04-22 | Mr. Daniel J. ApelCFO | -13,10k | 934,29k | Automatic Disposition | 70,11 - 71,92 | 12,91k | -50,37% |
| 2026-04-23 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -10,00k | 750,00k | Automatic Disposition | 75,00 | 226,96k | -4,22% |
| 2026-03-05 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -10,00k | 641,90k | Automatic Disposition | 64,19 | 236,96k | -4,05% |
| 2026-01-06 | Mr. Patrick O'BrienCOO & Secretary | -2,50k | 0,00 | Other Disposition | - | 263,66k | -0,94% |
| 2026-01-05 | Mr. Patrick O'BrienCOO & Secretary | -49,49k | 3,12M | Automatic Disposition | 61,12 - 68,00 | 341,16k | -12,67% |
| 2025-12-31 | Mr. Patrick O'BrienCOO & Secretary | -2,80k | 0,00 | Other Disposition | - | 341,16k | -0,81% |
| 2026-01-05 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -40,16k | 2,53M | Automatic Disposition | 61,24 - 68,00 | 171,96k | -18,93% |
| 2026-01-02 | Dr. Christopher R. AnzaloneChairman, CEO & President | -13,19k | 871,70k | Automatic Disposition | 65,88 - 66,39 | 3,79M | -0,35% |
| 2025-12-29 | Dr. Christopher R. AnzaloneChairman, CEO & President | -51,73k | 3,26M | Derivative Exercise and Sale | 6,15 - 69,33 | 3,81M | - |
| 2025-12-26 | Dr. Mauro FerrariIndependent Director | -7,53k | 527,10k | Automatic Disposition | 70,00 | 61,23k | -10,95% |
| 2025-12-19 | Dr. Christopher R. AnzaloneChairman, CEO & President | -26,03k | 1,77M | Automatic Disposition | 66,67 - 68,85 | 3,81M | -0,68% |
| 2025-12-19 | Ms. Victoria M. VakienerIndependent Director | -10,04k | 679,49k | Automatic Disposition | 66,63 - 68,39 | 27,90k | -26,46% |
| 2025-12-19 | Mr. William D. WaddillIndependent Lead Director | -8,37k | 566,04k | Automatic Disposition | 66,66 - 68,53 | 48,74k | -14,65% |
| 2025-12-19 | Dr. Adeoye Y. OlukotunIndependent Director | -10,00k | 676,62k | Automatic Disposition | 66,70 - 68,48 | 33,60k | -22,94% |
| 2025-12-17 | Dr. Christopher R. AnzaloneChairman, CEO & President | -85,00k | 5,44M | Vente | 63,55 - 66,30 | 3,83M | -2,17% |
| 2025-12-15 | Dr. Christopher R. AnzaloneChairman, CEO & President | -184,30k | 12,35M | Vente | 60,51 - 69,96 | 3,92M | -4,49% |
| 2025-12-05 | Dr. Michael Steven PerryIndependent Director | -16,25k | 991,74k | Vente | 61,03 | 98,51k | -14,16% |
| 2025-11-28 | Dr. Mauro FerrariIndependent Director | -8,75k | 493,41k | Vente | 56,39 | 52,03k | -14,40% |
| 2025-10-01 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -20,00k | 700,00k | Automatic Disposition | 35,00 | 212,12k | -8,62% |
| 2025-09-12 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -15,00k | 450,00k | Automatic Disposition | 30,00 | 232,12k | -6,07% |
| 2025-09-02 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -15,00k | 375,00k | Automatic Disposition | 25,00 | 247,12k | -5,72% |
| 2025-08-13 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -10,00k | 200,00k | Automatic Disposition | 20,00 | 262,12k | -3,67% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
